Name | Nazareth Home |
---|---|
Location | 2000 Newburg Road, Louisville, Kentucky |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 118 |
Occupancy Rate | 83.05% |
Medicare ID (CCN) | 185138 |
Legal Business Name | Nazareth Home Inc |
Ownership Type | For Profit - Corporation |
NPI Number | 1346312824 |
Organization Name | NAZARETH HOME INC |
Doing Business As | NAZARETH LITERARY & BENEVOLENT INSTITUTION NAZARETH HOME |
Address | 2000 Newburg Rd, Louisville, KY 40205 |
Phone Number | 502-459-9681 |
News Archive
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the pricing of an underwritten public offering of 13,000,000 shares of its common stock at a price to the public of $7.25 per share.
One of the biggest problems in fighting breast cancer is the lack of inexpensive, early detection diagnostic tools.
The rapidly growing field of nanotechnology and its future use in cosmetic products holds both enormous potential and potential concern for consumers. Currently, major cosmetic manufacturers have imposed a voluntary ban on the use of nanoparticles in products while they await a ruling from the Food and Drug Administration regarding the safety of this technology.
Kadimastem, an Israeli Biotechnology company that develops human pluripotent stem cell-related products, today announced the signing of a five year framework agreement with Merck Serono, a division of Merck KGaA, Darmstadt, Germany.
› Verified 3 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the pricing of an underwritten public offering of 13,000,000 shares of its common stock at a price to the public of $7.25 per share.
One of the biggest problems in fighting breast cancer is the lack of inexpensive, early detection diagnostic tools.
The rapidly growing field of nanotechnology and its future use in cosmetic products holds both enormous potential and potential concern for consumers. Currently, major cosmetic manufacturers have imposed a voluntary ban on the use of nanoparticles in products while they await a ruling from the Food and Drug Administration regarding the safety of this technology.
Kadimastem, an Israeli Biotechnology company that develops human pluripotent stem cell-related products, today announced the signing of a five year framework agreement with Merck Serono, a division of Merck KGaA, Darmstadt, Germany.
› Verified 3 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 13.54 | 14.46 |
Percentage of long-stay residents who lose too much weight | 7.26 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 55.46 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.27 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 1.42 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0.66 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0.65 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 4.23 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.37 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 12.38 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 95.78 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 1.11 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 13.43 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 27.03 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 10.23 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.11 | 95.98 |
Percentage of short-stay residents who made improvements in function | 77.33 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 95.12 | 82.93 |
News Archive
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the pricing of an underwritten public offering of 13,000,000 shares of its common stock at a price to the public of $7.25 per share.
One of the biggest problems in fighting breast cancer is the lack of inexpensive, early detection diagnostic tools.
The rapidly growing field of nanotechnology and its future use in cosmetic products holds both enormous potential and potential concern for consumers. Currently, major cosmetic manufacturers have imposed a voluntary ban on the use of nanoparticles in products while they await a ruling from the Food and Drug Administration regarding the safety of this technology.
Kadimastem, an Israeli Biotechnology company that develops human pluripotent stem cell-related products, today announced the signing of a five year framework agreement with Merck Serono, a division of Merck KGaA, Darmstadt, Germany.
› Verified 3 days ago
Christian Health Center Location: 920 South Fourth Street, Louisville, Kentucky 40203 Phone: (502) 583-6533 | |
Highlands Nursing And Rehabilitation Location: 1705 Stevens Avenue, Louisville, Kentucky 40205 Phone: (502) 451-7330 | |
Hillcreek Rehab And Care, Llc Location: 3116 Breckenridge Lane, Louisville, Kentucky 40220 Phone: (502) 459-9120 | |
Landmark Of Iroquois Park Rehab And Nursing Center Location: 900 Gagel Avenue, Louisville, Kentucky 40216 Phone: (502) 368-5827 | |
Landmark Of Louisville Rehabilitation And Nursing Location: 1155 Eastern Parkway, Louisville, Kentucky 40217 Phone: (502) 636-5241 | |
Franciscan Health Care Center Location: 3625 Fern Valley Road, Louisville, Kentucky 40219 Phone: (502) 964-3381 |